Skip to main content
. Author manuscript; available in PMC: 2014 Feb 12.
Published in final edited form as: Circulation. 2013 Jan 11;127(6):691–702. doi: 10.1161/CIRCULATIONAHA.112.128132

Table 2.

Baseline physical condition and laboratory values*

Entire
Cohort
n=150
VAD
Infection
Group
n=33
No VAD
Infection
Group
n=117
Hazard Ratio
(95% CI)
P value
Temperature °C 36.6 (0.6) 36.4 (0.6) 36.7 (0.6) 0.53 (0.29–0.95) 0.03
Body Mass Index 28.0 (5.3) 29.1 (6.2) 27.7 (5.0) 1.04 (0.98–1.11) 0.16
Cachexia (%) 27 (18) 6 (19) 21 (18) 1.03 (0.42–2.49) 0.96
Dialysis (%) 6 (4) 2 (6) 4 (3) 2.48 (0.59–10.4) 0.22
Mechanical
ventilation (%) 15 (10) 3 (9) 12 (10) 1.62 (0.49–5.37) 0.43
Baseline Laboratory Values
Leukocyte count/mm3 8.7 (4.0) 8.8 (3.0) 8.7 (4.3) 1.04 (0.95–1.13) 0.43
Hematocrit, % 34.8 (5.8) 36.2 (6.4) 34.4 (5.6) 1.04 (0.98–1.10) 0.19
Glucose mg/dL 123 (45) 118 (40) 124 (47) 1.00 (0.99–1.01) 1.00
Creatinine
mg/dL 1.6 (0.7) 1.7 (0.7) 1.5 (0.7) 1.57 (1.00–2.45) 0.05
Albumin g/DL 3.5 (0.6) 3.4 (0.6) 3.5 (0.6) 0.70 (0.38–1.28) 0.25
Total bilirubin mg/dL 1.4 (1.0) 1.7 (1.5) 1.4 (0.82) 1.37 (1.02–1.83) 0.04
Alanine
aminotransferase U/L 75 (144) 72 (138) 76 (147) 1.00 (0.997–1.002) 0.86
Aspartate
aminotransferase
U/L
69 (134) 66 (132) 69 (135) 1.00 (0.997–1.003) 0.89
*

Values are mean and SD unless otherwise stated

Subjects with missing data are excluded